Protalix BioTherapeutics (PLX) Receivables - Other (2010 - 2019)

Protalix BioTherapeutics (PLX) recorded quarterly Receivables - Other of $26000.0 in Q4 2019, down 99.0% quarter-over-quarter from $2.6 million in Q1 2014.

Protalix BioTherapeutics (PLX) Receivables - Other (2010 - 2019) Analysis & Trends

Protalix BioTherapeutics' Receivables - Other history runs 6 years deep, the most recent figure standing at $26000.0 for Q4 2019.

  • In Q4 2019, Receivables - Other changed N/A year-over-year to $26000.0; the TTM figure through Dec 2019 stood at $26000.0 (changed N/A YoY), while the FY2019 annual figure was $26000.0, changed N/A from the prior year.
  • Receivables - Other was $26000.0 for Q4 2019 at Protalix BioTherapeutics, down from $2.6 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $26000.0 in Q4 2019 to a low of $26000.0 in Q4 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Protalix BioTherapeutics 176.47 Mn 165.67 Mn 29.62 Mn

Historic Data

Download Data
DateValue
Dec 31, 2019 26,000.00
Dec 31, 2019 26,000.00
Mar 31, 2014 2.61 Mn
Mar 31, 2014 2.61 Mn
Dec 31, 2013 1.46 Mn
Dec 31, 2013 1.46 Mn
Sep 30, 2013 4.17 Mn
Sep 30, 2013 4.17 Mn
Jun 30, 2013 3.59 Mn
Jun 30, 2013 3.59 Mn
Mar 31, 2013 3.55 Mn
Mar 31, 2013 3.55 Mn
Dec 31, 2012 3.69 Mn
Dec 31, 2012 3.69 Mn
Sep 30, 2012 3.28 Mn
Sep 30, 2012 3.28 Mn
Jun 30, 2012 4.05 Mn
Jun 30, 2012 4.05 Mn
Mar 31, 2012 3.15 Mn
Mar 31, 2012 3.15 Mn